Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liqi Huoxue
- Development stage
- Unknown
- Lead developer
- Guizhou Yibai Pharmaceutical
- Administration
- Oral
01
Overview
Liqi Huoxue dropping pills (also known as LQHXDP) is an approved traditional Chinese medicine (TCM) and Miao patent medicine developed by Guizhou Yibai Pharmaceutical and its subsidiary Guizhou Yibai Women's Pharmacy for the treatment of cardiovascular diseases. The formulation is composed of four main active ingredients: Cinnamomum migao oil (Litsea lancilimba Merr. oil), Allii Macrostemonis Bulbus (Allium macrostemon Bunge), Chuanxiong Rhizoma (Sichuan lovage rhizome), and l-Borneolum. It is primarily indicated for coronary heart disease (CHD) and stable or unstable angina pectoris. Liqi Huoxue exerts cardioprotective effects by promoting blood circulation, regulating qi, reducing myocardial inflammation, improving endothelial function, and protecting cardiomyocytes from ischemia-reperfusion injury.
- Other names
- LQHXDPLQHXDWLiqi Huoxue Dropping PillLiqi Huoxue dropping pills
02
Targets
AKT (RAC-alpha serine/threonine-protein kinase)GSK3 (Glycogen synthase kinase 3 beta)MLKL (Mixed lineage kinase domain-like protein)RIPK1 (Receptor-interacting serine/threonine-protein kinase 1)RIPK3
Beyond the preview
Go deeper on Liqi Huoxue.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Liqi Huoxue.